Depreciation of Revolution Medicines, Inc. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Revolution Medicines, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2021 to 31 Dec 2025.
  • Revolution Medicines, Inc. Depreciation for the quarter ending 31 Dec 2025 was $2,100,000, a 40% increase year-over-year.
  • Revolution Medicines, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $7,400,000, a 19% increase year-over-year.
  • Revolution Medicines, Inc. annual Depreciation for 2025 was $7,400,000, a 19% increase from 2024.
  • Revolution Medicines, Inc. annual Depreciation for 2024 was $6,200,000, a 24% increase from 2023.
  • Revolution Medicines, Inc. annual Depreciation for 2023 was $5,000,000, a 25% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Revolution Medicines, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $7,400,000 $2,100,000 +$600,000 +40% 01 Oct 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $6,800,000 $2,000,000 +$400,000 +25% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $6,400,000 $1,700,000 +$100,000 +6.2% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $6,300,000 $1,600,000 +$100,000 +6.7% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $6,200,000 $1,500,000 +$205,000 +16% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $5,995,000 $1,600,000 +$300,000 +23% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $5,695,000 $1,600,000 +$400,000 +33% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $5,295,000 $1,500,000 +$295,000 +24% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $5,000,000 $1,295,000 +$95,000 +7.9% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
Q3 2023 $4,905,000 $1,300,000 +$300,000 +30% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $4,605,000 $1,200,000 +$300,000 +33% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $4,305,000 $1,205,000 +$305,000 +34% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $4,000,000 $1,200,000 01 Oct 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
Q3 2022 $1,000,000 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $900,000 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q1
Q1 2022 $900,000 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1

Revolution Medicines, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $7,400,000 +$1,200,000 +19% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $6,200,000 +$1,200,000 +24% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $5,000,000 +$1,000,000 +25% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $4,000,000 +$917,000 +30% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 $3,083,000 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.